Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, July 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 318 articles:
HTML format


 

Single Articles

  1. BENKHALED S, Diakite K, Jullian N, Poeta S, et al
    Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Radiat Oncol. 2023;18:105.
    PubMed    
    Abstract available

  2. QIAN W, Chen Q, Hu C
    Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis for Assessing Normal-Sized Lymph Node Metastasis in Cervical Cancer: Comparison Between Readout-Segmented and Single-Shot Echo-Planar Diffusion-Weighted Imaging.
    J Comput Assist Tomogr. 2023 Mar 9. doi: 10.1097/RCT.0000000000001463.
    PubMed    
    Abstract available

  3. LIU H, Sun L, Lian J, Wang L, et al
    Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer.
    J Cancer Res Clin Oncol. 2023 Jun 28. doi: 10.1007/s00432-023-05020.
    PubMed    
    Abstract available

  4. EL-ZEIN M, Ali R, Farah E, Botting-Provost S, et al
    Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    Elife. 2023;12:e83764.
    PubMed    
    Abstract available

  5. ZHINGRE A, Bedoya-Pilozo C, Gutierrez-Pallo D, Badano I, et al
    Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador.
    Viruses. 2023;15:1393.
    PubMed    
    Abstract available

  6. NGUYEN HDT, Le TM, Lee E, Lee D, et al
    Relationship between Human Papillomavirus Status and the Cervicovaginal Microbiome in Cervical Cancer.
    Microorganisms. 2023;11:1417.
    PubMed    
    Abstract available

  7. KANG HJ, Kwak YK, Lee SJ, Kim M, et al
    Re-Irradiation with Intensity-Modulated Radiation Therapy for the Treatment of Recurrent Cervical Cancer in the Pelvis: An Analysis of Outcomes and Toxicity.
    Medicina (Kaunas). 2023;59:1164.
    PubMed    
    Abstract available

  8. AVESANI G, Perazzolo A, Amerighi A, Celli V, et al
    The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review.
    Life (Basel). 2023;13:1368.
    PubMed    
    Abstract available

  9. KIM S, An H, Cho HW, Min KJ, et al
    Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis.
    J Clin Med. 2023;12:4024.
    PubMed    
    Abstract available

  10. ALFANO A, Cafferata EGA, Gangemi M, Nicola Candia A, et al
    In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer.
    Int J Mol Sci. 2023;24:9992.
    PubMed    
    Abstract available

  11. VALLE-MENDIOLA A, Gutierrez-Hoya A, Soto-Cruz I
    JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Genes (Basel). 2023;14:1141.
    PubMed    
    Abstract available

  12. ZILIENE E, Inciura A, Ugenskiene R, Juozaityte E, et al
    Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene.
    Diagnostics (Basel). 2023;13:1999.
    PubMed    
    Abstract available

  13. PASCIUTO T, Moro F, Collarino A, Gambacorta MA, et al
    The Role of Multimodal Imaging in Pathological Response Prediction of Locally Advanced Cervical Cancer Patients Treated by Chemoradiation Therapy Followed by Radical Surgery.
    Cancers (Basel). 2023;15:3071.
    PubMed    
    Abstract available

  14. MENGESHA MB, Chekole TT, Hidru HD
    Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:338.
    PubMed    
    Abstract available

  15. ZHANG K, Ji X, Song Z, Song W, et al
    Butyrate inhibits the mitochondrial complex Iota to mediate mitochondria-dependent apoptosis of cervical cancer cells.
    BMC Complement Med Ther. 2023;23:212.
    PubMed    
    Abstract available

  16. LI Q, Xie B, Chen X, Lu B, et al
    SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation.
    Cell Death Discov. 2023;9:192.
    PubMed    
    Abstract available

  17. YAO S, Xu J, Zhao K, Song P, et al
    Correction: Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
    Cell Death Dis. 2023;14:377.
    PubMed    


  18. ELEMES S, Stachteas P, Haidich AB, Mamopoulos A, et al
    The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.
    In Vivo. 2023;37:1455-1476.
    PubMed    
    Abstract available

  19. IMAI K, Chikazawa K, Kuwata T, Konno R, et al
    Volume Index Measured Using Magnetic Resonance Imaging for Diagnosing Cervical Cancer Tumors <2 cm.
    In Vivo. 2023;37:1786-1789.
    PubMed    
    Abstract available

  20. WILLOWS K, Selk A, Auclair MH, Jim B, et al
    2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.
    Curr Oncol. 2023;30:5738-5768.
    PubMed    
    Abstract available

  21. MOHAMADIAN N, Nasseri S, Hosseini S, Molaie F, et al
    Dosimetric impact of bladder volume on organs at risk during external beam radiotherapy of cervical cancer.
    Radiat Prot Dosimetry. 2023 Jun 26:ncad183. doi: 10.1093.
    PubMed    
    Abstract available

  22. SINGHAI M, Pandey V, Ashique S, Gupta GD, et al
    Design and evaluation of SLNs encapsulated curcumin-based topical formulation for the management of cervical cancer.
    Anticancer Agents Med Chem. 2023 Jun 26. doi: 10.2174/1871520623666230626145750.
    PubMed    
    Abstract available

  23. SHIN MB, Oluoch LM, Barnabas RV, Baynes C, et al
    Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
    Implement Sci. 2023;18:26.
    PubMed    
    Abstract available

  24. MUTHURAMALINGAM MR, Muraleedharan VR
    Patterns in the prevalence and wealth-based inequality of cervical cancer screening in India.
    BMC Womens Health. 2023;23:337.
    PubMed    
    Abstract available

  25. SOEJIMA Y, Fujiwara T, Fujii M, Tsushima H, et al
    Arthroscopic Treatment of Septic Arthritis of the Ankle Caused by Group B Streptococcus: A Case Report.
    Am J Case Rep. 2023;24:e939719.
    PubMed    
    Abstract available

  26. ASHIQUE S, Hussain A, Fatima N, Altamimi MA, et al
    HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective.
    Virusdisease. 2023 May 24:1-19. doi: 10.1007/s13337-023-00824.
    PubMed    
    Abstract available

  27. REY VALZACCHI GM, Odetto D, Saadi JM, Zamora LB, et al
    Conservative treatment of cervical cancer: A single center experience over a two-decade period.
    Gynecol Oncol Rep. 2023;48:101226.
    PubMed    
    Abstract available

  28. MCCARTHY AM, Tiro JA, Hu E, Ehsan S, et al
    Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems.
    Prev Med Rep. 2023;35:102279.
    PubMed    
    Abstract available

  29. ZHANG L, Alimu G, Du Z, Yan T, et al
    Functionalized Magnetic Nanoparticles for NIR-Induced Photothermal Therapy of Potential Application in Cervical Cancer.
    ACS Omega. 2023;8:21793-21801.
    PubMed    
    Abstract available

  30. HUANG Y, Zhang W, Yu Z, Su H, et al
    A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.
    Clin Med Insights Oncol. 2023;17:11795549231180832.
    PubMed    
    Abstract available

  31. MUKHERJEE AG, Ramesh Wanjari U, Valsala Gopalakrishnan A, Jayaraj R, et al
    HPV-associated cancers: insights into the mechanistic scenario and latest updates.
    Med Oncol. 2023;40:212.
    PubMed    
    Abstract available

  32. XIE H, Wei M, Yao L, Liu Y, et al
    The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.
    Microbiol Spectr. 2023 Jun 26:e0511722. doi: 10.1128/spectrum.05117.
    PubMed    
    Abstract available

  33. HU H, Zhao Q, Sang Y, Xiao Y, et al
    Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis.
    J Int Med Res. 2023;51:3000605231182557.
    PubMed    
    Abstract available

  34. JIANG P, Wei S, Bai Y, Qu A, et al
    The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study.
    Technol Cancer Res Treat. 2023;22:15330338231185013.
    PubMed    
    Abstract available

  35. ZHAI ZY, Li H, Li LW, Shen ZH, et al
    [Prognosis analysis of radical or modified radical hysterectomy and simple hysterectomy in patients with stage â…¡ endometrial cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:442-450.
    PubMed    
    Abstract available

  36. TAO H, Zeng D, Chen W, Li F, et al
    Focused ultrasound: a novel therapy for improving vaginal microecology in patients with high-risk HPV infection.
    Int J Hyperthermia. 2023;40:2211276.
    PubMed    
    Abstract available

  37. MPACHIKA-MFIPA F, Kululanga LI, Mfipa D, Kazembe A, et al
    Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    BMC Womens Health. 2023;23:334.
    PubMed    
    Abstract available

  38. LIU J, Li S, Cao Q, Zhang Y, et al
    Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13756.
    PubMed    
    Abstract available

  39. LIEBERMANN E, Fontenot HB, Lim E, Matsunaga M, et al
    Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
    J Obstet Gynecol Neonatal Nurs. 2023 Jun 21:S0884-2175(23)00179.
    PubMed    
    Abstract available

  40. LIU Y, Zheng Z, Han J, Lin C, et al
    Delivery of sPD1 gene by anti-CD133 antibody conjugated microbubbles combined with ultrasound for the treatment of cervical cancer in mice.
    Toxicol Appl Pharmacol. 2023 Jun 22:116605. doi: 10.1016/j.taap.2023.116605.
    PubMed    
    Abstract available

  41. YU Y, Liu Y, Li Y, Yang X, et al
    Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:125.
    PubMed    


  42. STUEBS FA, Koch MC, Dietl AK, Schulmeyer CE, et al
    Management of Cervical Intraepithelial Neoplasia in Pregnant Women.
    Anticancer Res. 2023;43:3153-3158.
    PubMed    
    Abstract available

  43. GUO W, Jing W
    N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis.
    Drugs R D. 2023;23:165-174.
    PubMed    
    Abstract available

  44. DELLA CORTE L, Lavitola G, Bifulco G
    How endocervicoscopy can impact obstetric outcomes in women undergoing LEEP for CIN2 + : a retrospective cohort analysis.
    Arch Gynecol Obstet. 2023;308:507-513.
    PubMed    
    Abstract available

  45. MA Y, Xia X, Zheng W, Dai Y, et al
    HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic.
    Hum Vaccin Immunother. 2023;19:2212571.
    PubMed    
    Abstract available

  46. KREIJNE JE, Goetgebuer RL, Erler NS, De Boer NK, et al
    Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2023 May 23. doi: 10.1111/apt.17555.
    PubMed    
    Abstract available

  47. SAYINZOGA F, Tenet V, Heideman DAM, Sibomana H, et al
    Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
    Lancet Glob Health. 2023;11:e1096-e1104.
    PubMed    
    Abstract available

  48. MURENZI G, Mungo C
    Impact of the human papillomavirus vaccine in low-resource settings.
    Lancet Glob Health. 2023;11:e997-e998.
    PubMed    


  49. ZHANG L, Yu K, Zhu B, Mei S, et al
    Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis.
    Hum Vaccin Immunother. 2023;19:2207441.
    PubMed    
    Abstract available

  50. WANG S, Zhou X, Niu S, Chen L, et al
    Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance.
    Mod Pathol. 2023;36:100148.
    PubMed    
    Abstract available

  51. SHI R, Qi W, Cai J, Zhao M, et al
    Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
    Arch Gynecol Obstet. 2023;308:551-559.
    PubMed    
    Abstract available

  52. AHMED W, Zaib S, Ullah S, Fatima A, et al
    Role of Human Papillomavirus in Various Cancers: Epidemiology, Screening and Prevention.
    Mini Rev Med Chem. 2023;23:1079-1089.
    PubMed    
    Abstract available

  53. YAN K, Hu C, Liu C, Chu G, et al
    LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Histol Histopathol. 2023;38:823-835.
    PubMed    
    Abstract available

  54. ZHANG J, Yang Y, Gao Y, Bai Z, et al
    Non-interference delivery of Ce6 and DOX in NIR light-responsive liposomes for synergetic cervical cancer therapy.
    Biomed Mater. 2023 Jul 5. doi: 10.1088/1748.
    PubMed    
    Abstract available

  55. WUORI D, Skala SL, Chapel DB
    Herpes Pseudotumor Mimicking Cervical Cancer With Lymph Node Metastasis in an Immunocompetent Patient.
    Int J Gynecol Pathol. 2023 Jun 15. doi: 10.1097/PGP.0000000000000964.
    PubMed    
    Abstract available

  56. BASAGOITIA A, Burrowes S, Solis-Soto MT, MacMillan G, et al
    Community and provider perceptions and experiences of cervical cancer screening in Rural Bolivia: a qualitative study.
    BMC Womens Health. 2023;23:359.
    PubMed    
    Abstract available

  57. GOMES MLS, Moura NDS, Magalhaes LC, da Silva RR, et al
    Systematic literature review of primary and secondary cervical cancer prevention programs in South America.
    Rev Panam Salud Publica. 2023;47:e96.
    PubMed    
    Abstract available

  58. THAHIRABANUIBRAHIM, Logaraj M
    The effect of the health belief model education for cervical cancer prevention, screening promotion among rural women in Chengalpattu district, Tamil Nadu (HBMECC).
    J Educ Health Promot. 2023;12:166.
    PubMed    
    Abstract available

  59. CHENG JM, Luo WX, Tan BG, Pan J, et al
    Whole-tumor histogram analysis of apparent diffusion coefficients for predicting lymphovascular space invasion in stage IB-IIA cervical cancer.
    Front Oncol. 2023;13:1206659.
    PubMed    
    Abstract available

  60. NEUMEYER S, Tanaka LF, Liang LA, Klug SJ, et al
    Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data.
    Cancer Med. 2023 Jul 5. doi: 10.1002/cam4.6318.
    PubMed    
    Abstract available

  61. SAWAYA GF, Dorismond VG
    Avoiding Low-Value Care and Patient Financial Harm in Cervical Cancer Screening.
    Cancer Prev Res (Phila). 2023;16:363-364.
    PubMed    
    Abstract available

  62. ZHANG M, Hong X, Ma N, Wei Z, et al
    The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
    J Transl Med. 2023;21:433.
    PubMed    
    Abstract available

  63. ARI ES, Dioso RIP, Sotunsa JO
    Improving care seeking behavior toward cervical cancer screening participation among Gwafan community women, North-Central Nigeria.
    BMC Womens Health. 2023;23:356.
    PubMed    
    Abstract available

  64. VIDRINE JI, Fennell BS, Simmons VN, Sutton SK, et al
    Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial.
    BMC Public Health. 2023;23:1284.
    PubMed    
    Abstract available

  65. ZHANG N, Jin X, Yang W, Gu C, et al
    Survival outcomes of abdominal radical hysterectomy, laparoscopic radical hysterectomy, robot-assisted radical hysterectomy and vaginal radical hysterectomy approaches for early-stage cervical cancer: a retrospective study.
    World J Surg Oncol. 2023;21:197.
    PubMed    
    Abstract available

  66. KONG X, Xiong Y, Xue M, He J, et al
    Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer.
    Sci Rep. 2023;13:10697.
    PubMed    
    Abstract available

  67. HAN YH, Ma DY, Lee SJ, Mao YY, et al
    Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape.
    Cancer Genomics Proteomics. 2023;20:383-397.
    PubMed    
    Abstract available

  68. ROMAN C, Andrade D, Hernandez Y, Salazar ZK, et al
    Biological, demographic, and health factors associated with HPV infection in Ecuadorian women.
    Front Public Health. 2023;11:1158270.
    PubMed    
    Abstract available

  69. MANN M, Singh VP, Kumar L
    Cervical cancer: a tale from HPV infection to PARP inhibitors.
    Genes Dis. 2022;10:1445-1456.
    PubMed    
    Abstract available

  70. SARIS DH, Pena D, Haggerty AF, Taunk NK, et al
    Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients.
    Gynecol Oncol Rep. 2023;47:101177.
    PubMed    
    Abstract available

  71. PACE LE, Hagenimana M, Dusengimana JV, Balinda JP, et al
    Implementation research: including breast examinations in a cervical cancer screening programme, Rwanda.
    Bull World Health Organ. 2023;101:478-486.
    PubMed    
    Abstract available

  72. LI Y, Wei Y, Zhang H, Bai Y, et al
    MicroRNA-154-5p suppresses cervical carcinoma growth and metastasis by silencing Cullin2 in vitro and in vivo.
    PeerJ. 2023;11:e15641.
    PubMed    
    Abstract available

  73. SONG Y, Wang S
    Melatonin synergistically enhances docetaxel induced endoplasmic reticulum stress to promote apoptosis by suppressing NF-kappaB activation in cervical cancer.
    Med Oncol. 2023;40:219.
    PubMed    
    Abstract available

  74. ALMASOUDI HH, Hakami MA, Alhazmi AY, Makkawi M, et al
    Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
    Med Oncol. 2023;40:218.
    PubMed    
    Abstract available

  75. NAGASE Y, Kobayashi E, Kobayashi M, Kakuda M, et al
    Intracorporeal colpotomy using the Gutclamper as a novel clamping device to prevent tumor spillage during laparoscopic radical hysterectomy for cervical cancer.
    Asian J Endosc Surg. 2023;16:658-661.
    PubMed    
    Abstract available

  76. LUO X, Liu J, Wang X, Wang Y, et al
    Circ_0005615 promotes cervical cancer cell growth and metastasis by modulating the miR-138-5p/KDM2A axis.
    J Biochem Mol Toxicol. 2023 Jul 2:e23410. doi: 10.1002/jbt.23410.
    PubMed    
    Abstract available

  77. PAN L, Shan RY, Gao SF, Zhou Y, et al
    Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer.
    Technol Health Care. 2023 Jun 29. doi: 10.3233/THC-230252.
    PubMed    
    Abstract available

  78. TONG L, Wu L
    Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
    BMC Womens Health. 2023;23:350.
    PubMed    
    Abstract available

  79. SHEN S, Jin H, Zhang X, Zhang Y, et al
    LINC00426, a novel m(6)A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.
    Cell Signal. 2023 Jun 29:110788. doi: 10.1016/j.cellsig.2023.110788.
    PubMed    
    Abstract available

  80. POLEBOYINA PK, Naik U, Pasha A, Ravinder D, et al
    Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-beta1 Potential Inhibitors to Curtail Cervical Cancer Progression.
    Appl Biochem Biotechnol. 2023 Jul 1. doi: 10.1007/s12010-023-04608.
    PubMed    
    Abstract available

  81. WAN Q, Xu J, Zhu C, Liu X, et al
    Alkaloids from Piper longum Exhibit Anti-inflammatory Activity and Synergistic Effects with Chemotherapeutic Agents against Cervical Cancer Cells.
    J Agric Food Chem. 2023 Jul 1. doi: 10.1021/acs.jafc.3c01667.
    PubMed    
    Abstract available

  82. SUN H, Liu Y, Yuan L, Wang N, et al
    Dosimetry study of Auto-VMAT planning and Manual-VMAT planning based on Pinnacle3 9.10 in radiotherapy for cervical cancer.
    Medicine (Baltimore). 2023;102:e34129.
    PubMed    
    Abstract available

  83. LIU MY, Li N
    The diagnostic value of lncRNA HOTAIR for cervical carcinoma in vaginal discharge and serum.
    Medicine (Baltimore). 2023;102:e34042.
    PubMed    
    Abstract available

  84. BORCHOWSKY K, Rush M, Mullally T, McBain L, et al
    Primary care experiences in the 'Let's test for HPV' study: a qualitative analysis.
    J Prim Health Care. 2023;15:147-154.
    PubMed    
    Abstract available

  85. ZANON JR, Durante H, Nobrega LM, Accorsi G, et al
    Emphysematous pyelonephritis after urinary diversion by percutaneous nephrostomy in patient with advanced cervical cancer: A case report.
    SAGE Open Med Case Rep. 2023;11:2050313X231182532.
    PubMed    
    Abstract available

  86. FU C, Wang C, Qian Q, Zhang Y, et al
    A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.
    Gynecol Oncol Rep. 2023;48:101228.
    PubMed    
    Abstract available

  87. SCANNING
    Retracted: Application of MRI and CT Images in Surgical Treatment of Early Cervical Cancer.
    Scanning. 2023;2023:9847106.
    PubMed    
    Abstract available

  88. MARKERS D
    Retracted: Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function.
    Dis Markers. 2023;2023:9781835.
    PubMed    
    Abstract available

  89. BROSNAN B, Skarga-Bandurova I, Biloborodova T, Skarha-Bandurov I, et al
    Cervical Intraepithelial Neoplasia Grading from Prepared Digital Histology Images.
    Stud Health Technol Inform. 2023;305:402-405.
    PubMed    
    Abstract available

  90. PETENI S, Ozoemena OC, Khawula T, Haruna AB, et al
    Electrochemical Immunosensor for Ultra-Low Detection of Human Papillomavirus Biomarker for Cervical Cancer.
    ACS Sens. 2023 Jun 29. doi: 10.1021/acssensors.3c00677.
    PubMed    
    Abstract available

  91. DI FONTE R, Strippoli S, Garofoli M, Cormio G, et al
    Cervical cancer benefits from trabectedin combination with the beta-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.
    Front Cell Dev Biol. 2023;11:1178316.
    PubMed    
    Abstract available

  92. RAI R, Conrad R, Benbrook DM
    Dataset on mucin 1 and 4 proteins and SialyT and T antigens staining patterns in cervical cancer primary tumors and metastatic lymph nodes.
    Data Brief. 2023;48:109243.
    PubMed    
    Abstract available

  93. PONTRE JC, Nathan E, Goldsmith H, McElhinney B, et al
    Does the New National Cervical Screening Programme Guideline Detect Cases of High-Grade Squamous Intraepithelial Lesions That Previously Would Have Been Missed?
    J Low Genit Tract Dis. 2023;27:230-235.
    PubMed    
    Abstract available

  94. FAHMI MN, Kusuma F, Hellyanti T, Kekalih A, et al
    High ALDH-1 Expression Predicts Non-Complete Response of Radiotherapy in Stage III Squamous Cell Cervical Carcinoma Patients.
    Asian Pac J Cancer Prev. 2023;24:1863-1868.
    PubMed    
    Abstract available

  95. KARTIKEYAN R, Murugan D, Ajaykamal T, Varadhan M, et al
    Mixed ligand copper(II)-diimine complexes of 2-formylpyridine-N(4)-phenylthiosemicarbazone: diimine co-ligands tune the in vitro nanomolar cytotoxicity.
    Dalton Trans. 2023;52:9148-9169.
    PubMed    
    Abstract available

  96. SWAIN M, Budrukkar A, Rembielak A, Kron T, et al
    Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy.
    Clin Oncol (R Coll Radiol). 2023;35:489-496.
    PubMed    
    Abstract available

  97. FRANCOEUR AA, Furey KB, Ramirez J, Klomhaus AM, et al
    Recurrent High-Grade Squamous Intraepithelial Lesion After Loop Excision Procedure Versus Loop Procedure With Top Hat.
    J Low Genit Tract Dis. 2023;27:193-197.
    PubMed    
    Abstract available

  98. BERGER D, Van Dyk S, Beaulieu L, Major T, et al
    Modern Tools for Modern Brachytherapy.
    Clin Oncol (R Coll Radiol). 2023;35:e453-e468.
    PubMed    
    Abstract available

  99. HECKEN JM, Halagiera P, Rehman S, Tempfer CB, et al
    Virtual Reality for Anxiety Reduction in Women Undergoing Colposcopy: A Randomized Controlled Trial.
    J Low Genit Tract Dis. 2023;27:223-229.
    PubMed    
    Abstract available

  100. COOK IC, Fuhr LI, Flores SE, Novicoff WM, et al
    Cost-Conscious Colposcopy: A Single-Institution Review of Biopsy Submission Practices and Outcomes.
    J Low Genit Tract Dis. 2023;27:198-201.
    PubMed    
    Abstract available

  101. BOTHA MH, Van der Merwe FH, Snyman LC, Dreyer GJ, et al
    Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate.
    J Low Genit Tract Dis. 2023;27:212-216.
    PubMed    
    Abstract available

  102. CAUSIN RL, Sussuchi da Silva L, Leal LF, Possati-Resende JC, et al
    The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology.
    Cancer Cytopathol. 2023;131:454-464.
    PubMed    
    Abstract available

  103. IKENBERG H, Lieder S, Ahr A, Wilhelm M, et al
    Comparison of the Hologic Genius Digital Diagnostics System with the ThinPrep Imaging System-A retrospective assessment.
    Cancer Cytopathol. 2023;131:424-432.
    PubMed    
    Abstract available

  104. HARRIS LR
    Cervical Stenosis After Conization Associated With False-Negative Human Papillomavirus-Based Post-Treatment Testing.
    J Low Genit Tract Dis. 2023;27:300-301.
    PubMed    


  105. SINGH S, Prajapati YK
    Novel Bottom-Side Polished PCF-Based Plasmonic Biosensor for Early Detection of Hazardous Cancerous Cells.
    IEEE Trans Nanobioscience. 2023;22:647-654.
    PubMed    
    Abstract available

  106. XIAO J, Gong Y, Chen F, Chen L, et al
    Clinical Diagnostic Value of Atypical Glandular Cells in Cervical Cytology: A Single Center Experience From China.
    J Low Genit Tract Dis. 2023;27:202-206.
    PubMed    
    Abstract available

  107. GIOVANNETTI O, Tomalty D, Greco S, Kment B, et al
    Patient and provider perspectives on LEEP/LLETZ treatment and outcomes: an interview study.
    J Sex Med. 2023;20:977-990.
    PubMed    
    Abstract available

  108. ZARATE GDSF, Flores FLR, Burguete AI, Marina VM, et al
    Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model.
    Gynecol Obstet Invest. 2023;88:150-158.
    PubMed    
    Abstract available

  109. WU G, Li C, Yin L, Wang J, et al
    Compared between support vector machine (SVM) and deep belief network (DBN) for multi-classification of Raman spectroscopy for cervical diseases.
    Photodiagnosis Photodyn Ther. 2023;42:103340.
    PubMed    
    Abstract available

  110. LI X, Liu H, Zhang Y, Liu Y, et al
    A rare case of mesonephric adenocarcinoma in the uterine cervix.
    Asian J Surg. 2023;46:2936-2937.
    PubMed    


  111. ZHAO X, Song S, Wang Y, Mu X, et al
    Effects of photodynamic therapy in the treatment of high-grade vaginal intraepithelial lesions following hysterectomy and HPV infection.
    Photodiagnosis Photodyn Ther. 2023;42:103336.
    PubMed    
    Abstract available

  112. GUO N, Liu H
    A rare case of minimal-deviation adenocarcinoma of the uterine cervix with ovarian metastasis.
    Asian J Surg. 2023;46:2733-2734.
    PubMed    


  113. KITAMURA SI, Yoshida H, Kobayashi-Kato M, Kikkawa N, et al
    Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the Uterine Cervix: A Case Report and Literature Review.
    Int J Surg Pathol. 2023;31:819-824.
    PubMed    
    Abstract available

  114. JIANG D, Niu Z, Tan X, He H, et al
    The mortalities of female-specific cancers in China and other countries with distinct socioeconomic statuses: A longitudinal study.
    J Adv Res. 2023;49:127-139.
    PubMed    
    Abstract available

  115. SAUVAGET C, Selmouni F, Dangbemey DP, Kpebo DDO, et al
    Scaling-Up Cervical Cancer Screening and Treatment in Sub-Saharan Africa: Perspectives From Local Health Policymakers.
    JCO Glob Oncol. 2023;9:e2300115.
    PubMed    


  116. XIE H, Rao X, Li J, Yao L, et al
    Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy.
    Clin Chem Lab Med. 2023 Jul 13. doi: 10.1515/cclm-2023-0440.
    PubMed    
    Abstract available

  117. RAZZAK MA, Islam MN, Broti T, Kamal ES, et al
    Exploring usability problems of mHealth applications developed for cervical cancer: An empirical study.
    SAGE Open Med. 2023;11:20503121231180413.
    PubMed    
    Abstract available

  118. ANTABE R, Luginaah NA, Kangmennaang J, Mkandawire P, et al
    Determinants of cervical cancer screening among women living with HIV in Zimbabwe.
    Health Promot Int. 2023;38:daad073.
    PubMed    
    Abstract available

  119. GUO Y, Li T, Yang X, Qi Z, et al
    [Quantitative evaluation of radiotherapy plan in precise external beam radiotherapy process management for cervical cancer].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1035-1040.
    PubMed    
    Abstract available

  120. ZHANG F, Zhou M, Wang G, Li X, et al
    Evaluation of bladder filling effects on the dose distribution during radiotherapy for cervical cancer based on daily CT images.
    J Appl Clin Med Phys. 2023 Jul 12:e14097. doi: 10.1002/acm2.14097.
    PubMed    
    Abstract available

  121. YU Y, Liu Y, Li Y, Yang X, et al
    Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:135.
    PubMed    


  122. ZHONG J, Su M, Jiang Y, Huang L, et al
    VEGFR2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
    J Nanobiotechnology. 2023;21:220.
    PubMed    
    Abstract available

  123. HARLFINGER J, Sommer I, Gartlehner G
    [WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)].
    Gesundheitswesen. 2023;85:630-634.
    PubMed    
    Abstract available

  124. KHAN MJ
    Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations.
    Clin Obstet Gynecol. 2023 Jul 4. doi: 10.1097/GRF.0000000000000791.
    PubMed    
    Abstract available

  125. CICERON AC, Berg CJ, Clausen M, Jeon MJ, et al
    Development of a cervical cancer prevention text-messaging program for women living with HIV.
    Health Educ Res. 2023 Jul 12:cyad024. doi: 10.1093.
    PubMed    
    Abstract available

  126. LIU J, Li S, Cao Q, Zhang Y, et al
    ASO Author Reflections: Establishment of a Prediction Model for Recurrent Cervical Cancer During a 2-Year Follow-Up Period.
    Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13836.
    PubMed    


  127. GARCIA JC, Rios-Pena L, Rodriguez MCR, Maraver FM, et al
    Development and internal validation of a multivariable prediction model for the quality of life of cervical cancer survivors.
    J Obstet Gynaecol Res. 2023 Jul 12. doi: 10.1111/jog.15743.
    PubMed    
    Abstract available

  128. BI K, Yang J, Wei X
    Alternative splicing variants involved in pyroptosis and cuproptosis contribute to phenotypic remodeling of the tumor microenvironment in cervical cancer.
    Reprod Sci. 2023 Jul 11. doi: 10.1007/s43032-023-01284.
    PubMed    
    Abstract available

  129. OGUNSOLA OO, Olawepo JO, Ajayi O, Osayi E, et al
    AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings.
    BMJ Glob Health. 2023;8:e012311.
    PubMed    
    Abstract available

  130. KARADEMIR D, Ozgur A
    The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
    Med Oncol. 2023;40:234.
    PubMed    
    Abstract available

  131. MA T, Guo J, Han J, Li L, et al
    Circ_0001589/miR-1248/HMGB1 axis enhances EMT-mediated metastasis and cisplatin resistance in cervical cancer.
    Mol Carcinog. 2023 Jul 11. doi: 10.1002/mc.23605.
    PubMed    
    Abstract available

  132. NEGASH BA, Bayu NH, Woretaw AW
    Knowledge, attitude, and associated factor towards cervical cancer prevention among primary and secondary school female teachers in Gondar town, North West Ethiopia, 2022.
    BMC Womens Health. 2023;23:365.
    PubMed    
    Abstract available

  133. LI J, Qi C, Liu X, Li C, et al
    Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
    Sci Rep. 2023;13:11162.
    PubMed    


  134. CAO G, Yue J, Ruan Y, Han Y, et al
    Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment.
    EMBO J. 2023 Jul 10:e110757. doi: 10.15252/embj.2022110757.
    PubMed    
    Abstract available

  135. ZHU J, Jiang Q
    Twist1‑mediated transcriptional activation of Claudin‑4 promotes cervical cancer cell migration and invasion.
    Oncol Lett. 2023;26:335.
    PubMed    
    Abstract available

  136. GUO Y, Wang L, Xu Z, Li M, et al
    Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer.
    Front Oncol. 2023;13:1190251.
    PubMed    
    Abstract available

  137. ROBINSON D, Hoong K, Kleijn WB, Doronin A, et al
    Polarimetric imaging for cervical pre-cancer screening aided by machine learning: ex vivo studies.
    J Biomed Opt. 2023;28:102904.
    PubMed    
    Abstract available

  138. TAKENAKA T, Yamazaki H, Suzuki G, Masui K, et al
    Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy.
    J Contemp Brachytherapy. 2023;15:191-197.
    PubMed    
    Abstract available

  139. YAN C, Wang X, Wen A, Luo J, et al
    Comparative analysis of dosimetric and radiobiological models of IPSA and HIPO algorithms in combined intra-cavitary/interstitial brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2023;15:212-219.
    PubMed    
    Abstract available

  140. LUO Y, Chen Y, Jin H, Hou B, et al
    The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes.
    Acta Pharm Sin B. 2023;13:2645-2662.
    PubMed    
    Abstract available

  141. GUO L, Li C, Guo J, Qiu J, et al
    CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-kappaB signaling.
    Am J Cancer Res. 2023;13:2376-2391.
    PubMed    
    Abstract available

  142. LI X, Wu J, Wu Y, Duan Z, et al
    Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women.
    Int J Womens Health. 2023;15:987-1002.
    PubMed    
    Abstract available

  143. LING K, Dou Y, Yang N, Deng L, et al
    Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy.
    J Control Release. 2023 Jul 7:S0168-3659(23)00431.
    PubMed    
    Abstract available

  144. NAKAYITA RM, Benyumiza D, Nekesa C, Misuk I, et al
    Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.
    BMC Womens Health. 2023;23:362.
    PubMed    
    Abstract available

  145. YACOUTI A, Baddou R, El Mettat K, Guennouni M, et al
    Moroccan Women's Attitudes Regarding Pap Smear Test and Adherence to Cervical Cancer Screening.
    J Cancer Educ. 2023 Jul 7. doi: 10.1007/s13187-023-02317.
    PubMed    
    Abstract available

  146. JIANG S, Nan X, Pan X, Zhang J, et al
    The effect of aminolevulinic acid hydrochloride topical powder photodynamic therapy versus nocardia rubra cell wall skeleton and observers group in the treatment of cervical low-grade squamous intraepithelial lesions with human papillomavirus infectio
    Medicine (Baltimore). 2023;102:e34302.
    PubMed    
    Abstract available

  147. METHODS IN MEDICINE CAM
    Retracted: The Effect of Pilates Exercise Nursing Combined with Communication Standard-Reaching Theory Nursing and Pelvic Floor Muscle Training on Bladder Function and Family Function of Patients after Cervical Cancer Surgery.
    Comput Math Methods Med. 2023;2023:9786109.
    PubMed    
    Abstract available

  148. METHODS IN MEDICINE CAM
    Retracted: Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
    Comput Math Methods Med. 2023;2023:9869683.
    PubMed    
    Abstract available

  149. PATEL N, Bavikar R, Buch A, Kulkarni M, et al
    A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening.
    Gynecol Minim Invasive Ther. 2023;12:77-82.
    PubMed    
    Abstract available

  150. NAZARI E, Hasanzadeh M, Rezvani R, Rejali M, et al
    Association of dietary intake and cervical cancer: a prevention strategy.
    Infect Agent Cancer. 2023;18:42.
    PubMed    
    Abstract available

  151. MILESHKIN LR, Narayan K, Gaffney DK, Barnes EH, et al
    Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply.
    Lancet Oncol. 2023;24:e290.
    PubMed    


  152. SARI SY, Akdag NNS, Gultekin M, Yildiz F, et al
    Adjuvant chemotherapy for locally advanced cervical cancer.
    Lancet Oncol. 2023;24:e289.
    PubMed    


  153. EZECHI O, Akinsolu F, Salako A, Abodunrin O, et al
    High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis.
    J Int Med Res. 2023;51:3000605231182884.
    PubMed    
    Abstract available

  154. KAMBHAMPATI A, Meghani K, Ndlovu N, Monare B, et al
    A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa.
    Adv Radiat Oncol. 2023;8:101257.
    PubMed    
    Abstract available

  155. HARJANA NPA, Nita S, Sebayang M, Mukuan OS, et al
    Factors Associated With Utilization of Cervical Cancer Screening Program Among Women Living With HIV in Indonesia.
    Asia Pac J Public Health. 2023 Jul 5:10105395231185982.
    PubMed    


  156. YE X, Zou J, Chen J, Luo S, et al
    An adhesion-based method for rapid and low-cost isolation of circulating tumor cells.
    Clin Chim Acta. 2023;547:117421.
    PubMed    
    Abstract available

  157. LAGO V, Guijarro-Campillo AR, Vidal BS, Padilla-Iserte P, et al
    An Easy Learning Approach to a Complex Surgical Technique: A Step-by-Step Site-Relapse Lateral Extended Endopelvic Resection (LEER).
    Ann Surg Oncol. 2023;30:4991-4993.
    PubMed    
    Abstract available

  158. BERASALUCE GOMEZ A, Martin-Calvo N, Boria F, Manzour N, et al
    SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?
    Ann Surg Oncol. 2023;30:4975-4985.
    PubMed    
    Abstract available

  159. QUERLEU D, Bizzarri N, Ianieri MM, Scambia G, et al
    ASO Visual Abstract: Radical Vaginal Hysterectomy, Type B An Educational Video, Cadaver Model.
    Ann Surg Oncol. 2023;30:4990.
    PubMed    


  160. STAR J, Bandi P, Nargis N, Islami F, et al
    Updated Review of Major Cancer Risk Factors and Screening Test use in the United States, with a Focus on Changes During the COVID-19 Pandemic.
    Cancer Epidemiol Biomarkers Prev. 2023;32:879-888.
    PubMed    
    Abstract available

  161. THIPPANA M, Dwivedi A, Das A, Palanisamy M, et al
    Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis.
    Proteins. 2023;91:1173-1187.
    PubMed    
    Abstract available

  162. MORRIS VK, Jazaeri A, Westin SN, Pettaway C, et al
    Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers.
    Oncologist. 2023;28:618-623.
    PubMed    
    Abstract available

  163. QUERLEU D, Bizzarri N, Ianieri MM, Scambia G, et al
    Radical Vaginal Hysterectomy, Type B: An Educational Video, Cadaver Model.
    Ann Surg Oncol. 2023;30:4988-4989.
    PubMed    
    Abstract available

  164. BEFANO B, Campos NG, Egemen D, Herrero R, et al
    Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2023;115:788-795.
    PubMed    
    Abstract available

  165. LI S, Liu J, Guo R, Nickel MD, et al
    T(1) mapping and extracellular volume fraction measurement to evaluate the poor-prognosis factors in patients with cervical squamous cell carcinoma.
    NMR Biomed. 2023;36:e4918.
    PubMed    
    Abstract available

  166. SONG Y, Shou X, Sheng B, Mei J, et al
    Cell Membranes from Tumor-Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy.
    Adv Healthc Mater. 2023;12:e2202904.
    PubMed    
    Abstract available

  167. FLORES LEGARRETA A, Salvo G, Gonzales NR, Chisholm G, et al
    RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.
    J Gynecol Oncol. 2023;34:e50.
    PubMed    
    Abstract available

  168. HUANG HC, Chang PC, Li SF, Wang CY, et al
    The Significant Predictors for Breast, Cervical, Colorectal, or Oral Cancer Screening Intention and Behavior in Taiwan.
    Cancer Nurs. 2023;46:E261-E267.
    PubMed    
    Abstract available

  169. ZHAO F, Fang T, Liu H, Wang S, et al
    Long non-coding RNA MALAT1 promotes cell proliferation, migration and invasion in cervical cancer by targeting miR-625-5p and AKT2.
    Panminerva Med. 2023;65:266-267.
    PubMed    


  170. KITA M, Butsuhara Y, Hisamatsu Y, Yokoe T, et al
    Pneumovaginoscopy-assisted radical hysterectomy for early-stage cervical cancer: a novel bidirectional approach for tumor spillage prevention and R0 resection.
    J Gynecol Oncol. 2023 Jul 6. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  171. ZHOU X, Liang D, Li Q, Zhao L, et al
    The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study.
    J Gynecol Oncol. 2023 Jul 7. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  172. NICOLAI L, Yigit R, Bleeker MCG, Bart J, et al
    The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
    J Gynecol Oncol. 2023 Jul 7. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  173. METHODS IN MEDICINE CAM
    Retracted: Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9853237.
    PubMed    
    Abstract available

  174. DHAKAL K, Wang P, Mboineki JF, Getu MA, et al
    The distinct experience of supportive care needs among cervical cancer patients: A qualitative study.
    Tumori. 2023;109:394-405.
    PubMed    
    Abstract available


  175. Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression [Retraction].
    Onco Targets Ther. 2023;16:581-582.
    PubMed    
    Abstract available

  176. CHOU PC, Chen HC, Yeh CL, Hsu LC, et al
    [Improving the Pap Smear Screening Rate for Cervical Cancer in a Health Management Center: A Quality Improvement Program].
    Hu Li Za Zhi. 2023;70:77-86.
    PubMed    
    Abstract available

  177. JIANG W, Ouyang X, Li C, Long Y, et al
    Targeting PI3Kalpha increases the efficacy of anti-PD-1 antibody in cervical cancer.
    Immunology. 2023 Jul 19. doi: 10.1111/imm.13682.
    PubMed    
    Abstract available

  178. GU J, Ding B
    Cross-talk of pyroptosis-based subtypes, the development of a risk classifier and immune responses in cervical cancer.
    J Gene Med. 2023 Jul 19:e3566. doi: 10.1002/jgm.3566.
    PubMed    
    Abstract available

  179. YAN ZY, Di XH, Qiu Y, Ying YY, et al
    Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China.
    Virol J. 2023;20:156.
    PubMed    
    Abstract available

  180. SHI J, Rui X, Han C, Wang C, et al
    circRNF13, a novel N(6)-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.
    Cell Death Discov. 2023;9:253.
    PubMed    
    Abstract available

  181. WEI X, Sun K, Li S, Lin C, et al
    PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
    Tissue Cell. 2023;83:102151.
    PubMed    
    Abstract available

  182. KONG X, Xiong Y
    A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients.
    J Cancer Res Clin Oncol. 2023 Jul 19. doi: 10.1007/s00432-023-05158.
    PubMed    
    Abstract available

  183. HIDAYATULLAH A, Putra WE, Sustiprijatno S, Rifa'i M, et al
    Concatenation of molecular docking and dynamics simulation of human papillomavirus type 16 E7 oncoprotein targeted ligands: In quest of cervical cancer's treatment.
    An Acad Bras Cienc. 2023;95.
    PubMed    
    Abstract available

  184. THIANGPHAK E, Leetanaporn K, Buhachat R
    Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study.
    Obstet Gynecol Sci. 2023 Jul 19. doi: 10.5468/ogs.23119.
    PubMed    
    Abstract available

  185. GONG X, Chi H, Xia Z, Yang G, et al
    Advances in HPV-associated tumor management: Therapeutic strategies and emerging insights.
    J Med Virol. 2023;95:e28950.
    PubMed    
    Abstract available

  186. TIAN R, Li H, Ren S, Li S, et al
    circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis.
    Open Med (Wars). 2023;18:20230709.
    PubMed    
    Abstract available

  187. ZHENG Z, Hu K, Hou X, Yu L, et al
    Radiotherapy for postoperative vaginal recurrences of cervical squamous cell carcinoma: analysis of dosing and prognosis.
    J Obstet Gynaecol. 2023;43:2213328.
    PubMed    
    Abstract available

  188. ISHIMOTO T, Yagi A, Nakajima K, Okamoto N, et al
    A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Hum Vaccin Immunother. 2023;19:2229222.
    PubMed    
    Abstract available

  189. GILMAN SD, Gravitt PE, Paz-Soldan VA, Group PPS, et al
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: A case study from the Proyecto Precancer.
    Res Sq. 2023 Jul 7:rs.3.rs-3093534. doi: 10.21203/rs.3.rs-3093534.
    PubMed    
    Abstract available

  190. BASSAL R, Shalev V, Eisenberg VH, Stein-Reisner O, et al
    The Association Between Depression and Invasive and In-situ Cervical Tumors: A Large Population Based Cohort Study.
    Isr Med Assoc J. 2023;25:490-494.
    PubMed    
    Abstract available

  191. GYONGYOSI E, Laszlo B, Szalmas A, Konya J, et al
    Transcriptional activity of the long control region in human papillomavirus type 33 intratype variants.
    Virol J. 2023;20:152.
    PubMed    
    Abstract available

  192. FENG X, Shan R, Hu X
    The linkage of NF-kappaB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer.
    BMC Med Genomics. 2023;16:169.
    PubMed    
    Abstract available

  193. ZEWDIE A, Kasahun AW, Habtie A, Gashaw A, et al
    Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis.
    BMC Public Health. 2023;23:1369.
    PubMed    
    Abstract available

  194. LAKHMAN Y, Aherne EA, Jayaprakasam VS, Nougaret S, et al
    Staging of Cervical Cancer: A Practical Approach Using MRI and FDG PET.
    AJR Am J Roentgenol. 2023 Jun 7. doi: 10.2214/AJR.23.29003.
    PubMed    
    Abstract available

  195. LEATH CA 3RD, Nysenbaum J, Ting J, Zhang YJ, et al
    Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees.
    Am J Clin Oncol. 2023 Jul 17. doi: 10.1097/COC.0000000000001026.
    PubMed    
    Abstract available

  196. SIVARANJINI K, Oak A, Cheulkar S, Maheshwari A, et al
    Role of education and income on disparities of time-to-treatment initiation and its impact on cervical cancer survival.
    Indian J Public Health. 2023;67:235-239.
    PubMed    
    Abstract available

  197. GAO Y, Liu H, Wan J, Chang F, et al
    Construction and Assessment of a Prognostic Risk Model for Cervical Cancer Based on Lactate Metabolism-Related lncRNAs.
    Int J Gen Med. 2023;16:2943-2960.
    PubMed    
    Abstract available

  198. FAN C, Ma Q, Wu X, Dai X, et al
    Detection of DNA Methylation in Gene Loci ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 for Diagnosis of Cervical Cancer.
    Cancer Manag Res. 2023;15:635-644.
    PubMed    
    Abstract available

  199. JIANG S, Zheng J, Cui Z, Li Y, et al
    FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer.
    Front Cell Dev Biol. 2023;11:1200197.
    PubMed    
    Abstract available

  200. WANG T, Zhang H, Liu Y, Zhao C, et al
    Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations.
    J Clin Transl Pathol. 2023;3:75-83.
    PubMed    
    Abstract available

  201. SANTANA D, Gamboa OA, Saenz J, Esguerra JA, et al
    Morbidity of adjuvant treatment in early cervical cancer: a retrospective cohort study in a Latin American center.
    Rep Pract Oncol Radiother. 2023;28:189-197.
    PubMed    
    Abstract available

  202. LEE J, Ismail-Pratt I, Machalek DA, Kumarasamy S, et al
    The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions.
    Prev Med Rep. 2023;35:102291.
    PubMed    
    Abstract available

  203. ALSUBAI S, Alqahtani A, Sha M, Almadhor A, et al
    Privacy Preserved Cervical Cancer Detection Using Convolutional Neural Networks Applied to Pap Smear Images.
    Comput Math Methods Med. 2023;2023:9676206.
    PubMed    
    Abstract available

  204. ZHAO K, Han D, Tang L, Jin H, et al
    CD39 Expression in Peripheral T Cells is Associated with Clinicopathological Characteristics in Patients with Cervical Cancer.
    Iran J Immunol. 2023;20.
    PubMed    
    Abstract available

  205. CANDYSE LEMBA TSIMBA P, Magloire Anicet Boumba L, Pere H, Christy Nganga P, et al
    Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention.
    Infect Dis Now. 2023 Jul 14:104762. doi: 10.1016/j.idnow.2023.104762.
    PubMed    
    Abstract available

  206. STUEBS FA, Beckmann MW, Fehm T, Dannecker C, et al
    Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG).
    J Cancer Res Clin Oncol. 2023 Jul 15. doi: 10.1007/s00432-023-05132.
    PubMed    
    Abstract available

  207. STRELOW B, Francis M, Gertner G, Olson R, et al
    Saturday Pap Smear Clinic: addressing barriers to cervical cancer screening.
    BMJ Open Qual. 2023;12:e002252.
    PubMed    
    Abstract available

  208. LOPEZ-AMPUERO C, Hansen N, Larraondo MA, Taipe-Quico R, et al
    Squamocolumnar junction visibility among cervical cancer screening population in Peru might influence upper age for screening programs.
    Prev Med. 2023 Jul 12:107596. doi: 10.1016/j.ypmed.2023.107596.
    PubMed    
    Abstract available

  209. LI G, Moniod L, Chenafi S, Lamsisi M, et al
    Detection of HPV in urine for cervical cancer screening : feasibilty of an assay system.
    J Gynecol Obstet Hum Reprod. 2023 Jul 12:102631.
    PubMed    
    Abstract available

  210. XIANG X, Kang J, Jiang J, Zhang Y, et al
    A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
    Front Immunol. 2023;14:1198391.
    PubMed    
    Abstract available

  211. KUIPERS S, Godart J, Corbeau A, Sharfo AW, et al
    The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis.
    Front Oncol. 2023;13:1138433.
    PubMed    
    Abstract available

  212. SHARAFUTDINOVA KI, Shlyapina VS, Baeva AI, Timurshin AA, et al
    [Diabetes mellitus and the female reproductive system tumors].
    Probl Endokrinol (Mosk). 2023;69:103-110.
    PubMed    
    Abstract available

  213. SIRICO A, Simonelli S, Pignatiello S, Fulgione C, et al
    BDNF and NGF Expression in Preneoplastic Cervical Disease According to HIV Status.
    Int J Mol Sci. 2023;24:10729.
    PubMed    
    Abstract available

  214. PALAFOX-MARISCAL LA, Ortiz-Lazareno PC, Jave-Suarez LF, Aguilar-Lemarroy A, et al
    Pentoxifylline Inhibits TNF-alpha/TGF-beta1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-kappaB Pathway and SERPINE1 Expression in CaSki Cells.
    Int J Mol Sci. 2023;24:10592.
    PubMed    
    Abstract available

  215. OKONOGI N, Murata K, Yamada S, Habu Y, et al
    A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
    Int J Mol Sci. 2023;24:10565.
    PubMed    
    Abstract available

  216. KOSE B, Laar RV, Beekhuizen HV, Kemenade FV, et al
    Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer.
    Int J Mol Sci. 2023;24:10473.
    PubMed    
    Abstract available

  217. MKUU RS, Hall JM, Galochkina Z, Cho HD, et al
    Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis? A Nested Case-Control Study of a Florida Statewide Multisite EHR Database.
    Healthcare (Basel). 2023;11:1863.
    PubMed    
    Abstract available

  218. CHEON W, Han M, Jeong S, Oh ES, et al
    Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients.
    Cancers (Basel). 2023;15:3463.
    PubMed    
    Abstract available

  219. IVERS R, Levett T, Wynn K
    Cervical Screening Reminders for Aboriginal and Torres Strait Islander Women in Primary Care-Randomised Controlled Trial of Letter vs. Phone/SMS Reminders.
    Int J Environ Res Public Health. 2023;20:6257.
    PubMed    
    Abstract available

  220. DING R, Su Z, Chen M, Chen L, et al
    Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
    Medicine (Baltimore). 2023;102:e34313.
    PubMed    
    Abstract available

  221. SCARTH JA, Wasson CW, Patterson MR, Evans D, et al
    Exploitation of ATP-sensitive potassium ion (K(ATP)) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling.
    Oncogene. 2023 Jul 13. doi: 10.1038/s41388-023-02772.
    PubMed    
    Abstract available

  222. LI S, Shi L, Wang Y, Zhang L, et al
    FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Exp Cell Res. 2023;430:113719.
    PubMed    
    Abstract available

  223. BIAN L, Wang N, Tuersong K, Kaidierdan A, et al
    Oxygen vacancy engineering of TiO(2) nanosheets for enhanced photothermal therapy against cervical cancer in the second near-infrared window.
    Colloids Surf B Biointerfaces. 2023;229:113427.
    PubMed    
    Abstract available

  224. CESAR JA, Souto AM, Lelis CF, Pinheiro LP, et al
    Pap smears in the extreme South of Brazil: low coverage and exposure of the most vulnerable pregnant women.
    Rev Bras Epidemiol. 2023;26:e230032.
    PubMed    
    Abstract available

  225. MCGEE-AVILA JK, Richmond J, Henry KA, Stroup AM, et al
    Disparities in geospatial patterns of cancer care within urban counties and structural inequities in access to oncology care.
    Health Serv Res. 2023;58 Suppl 2.
    PubMed    
    Abstract available

  226. BAI A, Xue P, Li Q, Jiang Y, et al
    Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study.
    Cancer Med. 2023;12:14794-14805.
    PubMed    
    Abstract available

  227. NAKAGAWA M, Nakajima M, Inoue N, Takise S, et al
    Segmental cervical esophagectomy with free jejunal flap reconstruction for cervical esophageal cancer in patients with previous history of gastric surgery: a report of two cases.
    Clin J Gastroenterol. 2023;16:515-520.
    PubMed    
    Abstract available

  228. YE Y, Fu A, Cai J, Ma Z, et al
    Primary malignant melanoma of the cervix: A comprehensive analysis of case reports in the Chinese population.
    Cancer Med. 2023;12:14052-14061.
    PubMed    
    Abstract available

  229. DA SILVA NCH, Sonon P, Medeiros FS, da Silva MC, et al
    Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection.
    Hum Immunol. 2023;84:408-417.
    PubMed    
    Abstract available

  230. DIENDERE J, Kiemtore S, Coulibaly A, Tougri G, et al
    Low attendance in cervical cancer screening, geographical disparities and sociodemographic determinants of screening uptake among adult women in Burkina Faso : results from the first nationwide population-based survey.
    Rev Epidemiol Sante Publique. 2023;71:101845.
    PubMed    
    Abstract available

  231. YEN HK, Cheng SY, Chiu KN, Huang CC, et al
    Adding a nonpainful end to reduce pain recollection of Pap smear screening: a randomized controlled trial.
    Pain. 2023 Apr 12. doi: 10.1097/j.pain.0000000000002897.
    PubMed    
    Abstract available

  232. BLAUVELT A, Lebwohl M, Langley RG, Rowland K, et al
    Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials.
    J Am Acad Dermatol. 2023;89:274-282.
    PubMed    
    Abstract available

  233. NESSER W, Ayodele O
    Human Papilloma Virus Knowledge Among University Students, Staff, and Faculty in the State of Indiana During 2016, 2019, and 2022.
    J Community Health. 2023;48:718-723.
    PubMed    
    Abstract available

  234. GRIGOLO AV, Wendt GW, Lucio LC
    Factors Associated with HPV Knowledge Among Professionals in the City of Francisco Beltrao, Brazil.
    J Community Health. 2023;48:652-658.
    PubMed    
    Abstract available

  235. FEDELE F, Parazzini F, Vercellini P, Bergamini V, et al
    Reconstructive surgery for congenital atresia of the uterine cervix: a systematic review.
    Arch Gynecol Obstet. 2023;308:685-700.
    PubMed    
    Abstract available

  236. ZHAO F, Jastorff A, Hong Y, Hu S, et al
    Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
    Asia Pac J Clin Oncol. 2023;19:458-467.
    PubMed    
    Abstract available

  237. TONG T, Fan Q, Shi S, Li Y, et al
    Gastric-type mucinous adenocarcinoma of the cervix in a woman with Peutz-Jeghers syndrome: a case report.
    Acta Chir Belg. 2023;123:448-453.
    PubMed    
    Abstract available

  238. RAHMAN MA, Hasan MM, Hossain A, Alam KM, et al
    Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
    Asian Pac J Cancer Prev. 2023;24:2361-2368.
    PubMed    
    Abstract available

  239. HON HJ, Chong PP, Choo HL, Khine PP, et al
    A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons.
    Asian Pac J Cancer Prev. 2023;24:2207-2215.
    PubMed    
    Abstract available

  240. ZHANG M, Sit JWH, Wang T, Chan CWH, et al
    Exploring the sources of cervical cancer screening self-efficacy among rural females: A qualitative study.
    Health Expect. 2023 Jul 28. doi: 10.1111/hex.13840.
    PubMed    
    Abstract available

  241. DEVOTTA K, Vahabi M, Prakash V, Lofters AK, et al
    Implementation of a Cervical Cancer Screening Intervention for Under- or Never-Screened Women in Ontario, Canada: Understanding the Acceptability of HPV Self-Sampling.
    Curr Oncol. 2023;30:6786-6804.
    PubMed    
    Abstract available

  242. HWANG J, Moon H, Kim H, Kim KY, et al
    Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.
    Curr Issues Mol Biol. 2023;45:6154-6169.
    PubMed    
    Abstract available

  243. VENKATAS J, Singh M
    Curcumin-reduced gold nanoparticles facilitate IL-12 delivery to a cervical cancer in vitro cell model.
    Nanomedicine (Lond). 2023 Jul 28. doi: 10.2217/nnm-2023-0076.
    PubMed    
    Abstract available

  244. BIFULCO M
    Nobel laureate Harald zur Hausen passed. He was the first to discover the HPV-cervical cancer link.
    J Med Virol. 2023;95:e28982.
    PubMed    


  245. WOLF J, Xu Y
    Immune checkpoint inhibitor therapy in advanced cervical cancer: Deepened response with prolonged treatment and repeat response to re-initiation of therapy.
    Gynecol Oncol Rep. 2023;48:101244.
    PubMed    
    Abstract available

  246. SIMELANE SM, Munyakazi JB, Dlamini PG, Egbelowo OF, et al
    Projections of human papillomavirus vaccination and its impact on cervical cancer using the Caputo fractional derivative.
    Math Biosci Eng. 2023;20:11605-11626.
    PubMed    
    Abstract available

  247. BOWDEN SJ, Doulgeraki T, Bouras E, Markozannes G, et al
    Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
    BMC Med. 2023;21:274.
    PubMed    
    Abstract available

  248. MESFIN AH, Gufue ZH, Alemayehu MA, Kedida BD, et al
    Usage of cervical cancer screening services among HIV-positive women in Southern Ethiopia: a multicentre cross-sectional study.
    BMJ Open. 2023;13:e068253.
    PubMed    
    Abstract available

  249. SEIFERT F, Eisenblatter R, Beckmann J, Schurmann P, et al
    Association of two genomic variants with HPV type-specific risk of cervical cancer.
    Tumour Virus Res. 2023 Jul 25:200269. doi: 10.1016/j.tvr.2023.200269.
    PubMed    
    Abstract available

  250. BUSTAMANTE G, Liebermann E, McNair K, Fontenot HB, et al
    Women's perceptions and preferences for cervical cancer screening in light of updated guidelines.
    J Am Assoc Nurse Pract. 2023 Jul 27. doi: 10.1097/JXX.0000000000000923.
    PubMed    
    Abstract available

  251. XUE XL, Zhao S, Xu MC, Li Y, et al
    Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
    Neoplasma. 2023;70:430-442.
    PubMed    
    Abstract available

  252. WANG YN, Zhong ML, Liang MR, Yang JT, et al
    The therapeutic value of adjuvant chemotherapy after concurrent chemoradiotherapy for locally advanced cervical cancer.
    Gynecol Obstet Invest. 2023 Jul 27. doi: 10.1159/000533122.
    PubMed    
    Abstract available

  253. GUO S, Jiang H, Deng Y, Dong Y, et al
    Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer.
    J Obstet Gynaecol Res. 2023 Jul 27. doi: 10.1111/jog.15751.
    PubMed    
    Abstract available

  254. RAIS F, Boudam K, Menard C, Beauchemin MC, et al
    Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study.
    Phys Imaging Radiat Oncol. 2023;27:100467.
    PubMed    
    Abstract available

  255. ITTIAMORNLERT P, Jareemit N, Phianpiset R, Kuljarusnont S, et al
    High-risk human papillomavirus genotyping in women with atypical squamous cells of undetermined significance.
    Sci Rep. 2023;13:12134.
    PubMed    
    Abstract available

  256. ZHANG J, Xiang JD, Jia C, Du LF, et al
    Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in Staging Cervical Cancer: A Reliability Study.
    Ultrasound Med Biol. 2023 Jul 24:S0301-5629(23)00212.
    PubMed    
    Abstract available

  257. TUNG TH, Chen HW, Chou HH, Tsai JL, et al
    Does a one-session sexual health education program improve sexual confidence in patients with cervical cancer? A transtheoretical model-based clinical study.
    Arch Gynecol Obstet. 2023 Jul 26. doi: 10.1007/s00404-023-07141.
    PubMed    
    Abstract available

  258. GHOSE A, Agarwal A, Sirohi B, Nag S, et al
    Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India.
    Gynecol Oncol Rep. 2023;48:101247.
    PubMed    
    Abstract available

  259. JIN G, Li K, Niu S, Fan X, et al
    Efficacy and safety of intensity Modulated Radiation therapy combined with Concurrent Chemoradiotherapy in the treatment of Recurrent Cervical Cancer.
    Pak J Med Sci. 2023;39:1062-1067.
    PubMed    
    Abstract available

  260. ZHANG W, Chen M, Xiang Q, Sun S, et al
    Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer: a case report.
    Immunotherapy. 2023 Jul 25. doi: 10.2217/imt-2022-0044.
    PubMed    
    Abstract available

  261. SHIGETA S, Shimada M, Tsuji K, Watanabe Z, et al
    Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study.
    Sci Rep. 2023;13:12020.
    PubMed    
    Abstract available

  262. BERMUDEZ PC, Arrivillaga M, Torres Poveda K, Castrillon Libreros DM, et al
    Barriers to adherence to cytology exam: a case study in low-income Colombian women.
    BMC Health Serv Res. 2023;23:796.
    PubMed    
    Abstract available

  263. CHAN YM, Ismail MZH, Khaw WF
    Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    BMC Womens Health. 2023;23:389.
    PubMed    
    Abstract available

  264. BATMAN S, Varon ML, San Miguel-Majors SL, Benitez Majano S, et al
    Elimination of cervical cancer in Latin America (Project ECHO-ELA): lessons from phase one of implementation.
    Rev Panam Salud Publica. 2023;47:e113.
    PubMed    
    Abstract available

  265. ZENG WH, Liang Y, Zhou JQ, Lin HH, et al
    Comparison of the efficacy and safety of total laparoscopic hysterectomy without and with uterine manipulator combined with pelvic lymphadenectomy for early cervical cancer.
    J Obstet Gynaecol Res. 2023 Jul 24. doi: 10.1111/jog.15749.
    PubMed    
    Abstract available

  266. FISCHER AM, Hague T, Hoskin PJ
    CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer.
    Acta Oncol. 2023 Jul 24:1-9. doi: 10.1080/0284186X.2023.2238543.
    PubMed    
    Abstract available

  267. MAN I, Georges D, Sankaranarayanan R, Basu P, et al
    Building resilient cervical cancer prevention through gender-neutral HPV vaccination.
    Elife. 2023;12:e85735.
    PubMed    
    Abstract available

  268. ZHANG J, Li Y, Ren Y, Li J, et al
    miR-214-5p increases the radiosensitivity of cervical cancer by targeting ROCK1 expression.
    Adv Clin Exp Med. 2023 Jul 24. doi: 10.17219/acem/166673.
    PubMed    
    Abstract available

  269. FANG X, Hu P, Gao Y, Chen C, et al
    Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
    Adv Clin Exp Med. 2023 Jul 24. doi: 10.17219/acem/168342.
    PubMed    
    Abstract available


  270. Retraction: INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer.
    J Cell Mol Med. 2023 Jul 24. doi: 10.1111/jcmm.17859.
    PubMed    



  271. HPV and Cervical Cancer.
    J Midwifery Womens Health. 2023 Jul 23. doi: 10.1111/jmwh.13552.
    PubMed    


  272. LONG Y, Ren Y, Wei Q, Mobet Y, et al
    NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
    Int J Med Sci. 2023;20:1079-1090.
    PubMed    
    Abstract available

  273. MO X, Wang N, He Z, Kang W, et al
    The sub-molecular characterization identification for cervical cancer.
    Heliyon. 2023;9:e16873.
    PubMed    
    Abstract available

  274. AMIR SM, Idris IB, Said ZM, Yusoff HM, et al
    A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review.
    Iran J Public Health. 2023;52:1108-1120.
    PubMed    
    Abstract available

  275. KOMODA J, Hori T, Sato K, Kusajima K, et al
    Hypomagnesemia because of nedaplatin for cervical cancer: A case report.
    J Gen Fam Med. 2023;24:257-260.
    PubMed    
    Abstract available

  276. BAREK MA, Basher MA, Aziz MA, Hossen MS, et al
    Assessment of the association of CYP1A1 gene polymorphisms with the susceptibility of cervical cancer: A case-control study and meta-analysis.
    Heliyon. 2023;9:e17712.
    PubMed    
    Abstract available

  277. LIANG X, He H, Li Y, Chen S, et al
    An optimized robotic surgical technique for cervical cancer: investigating whether the use of the pulling robotic arm has better surgical outcomes.
    Front Oncol. 2023;13:1159081.
    PubMed    
    Abstract available

  278. ABDELMONSEF AHMED HA, Ibrahim Yassin SY, Mohamed Ahmed MS, Yousof Ali HZ, et al
    Application Of Health Belief Model About Cervical Cancer Screening Among Female Officer Employees In Kafr-El Sheikh University, Egypt.
    J Pak Med Assoc. 2023;73.
    PubMed    
    Abstract available

  279. LI P, Liu ZK, Zhao HY, Liu XY, et al
    [A risk prediction model of cervical cancer developed based on nested case-control design].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44:1139-1145.
    PubMed    
    Abstract available

  280. LADBURY C, Harkenrider M, Taunk N, Fisher C, et al
    A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
    Brachytherapy. 2023 Jul 20:S1538-4721(23)01595.
    PubMed    
    Abstract available

  281. HUO FC, Zhu ZM, Du WQ, Pan YJ, et al
    HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Pharmacol Res. 2023 Jul 20:106863. doi: 10.1016/j.phrs.2023.106863.
    PubMed    
    Abstract available

  282. BAUMANN M, von Knebel Doeberitz M
    Harald zur Hausen, virologist who linked viruses to cancer (1936-2023).
    Nature. 2023;619:693.
    PubMed    


  283. XIE N, Lin J, Liu L, Deng S, et al
    Nomograms constructed for predicting diagnosis and prognosis in cervical cancer patients with second primary malignancies: a SEER database analysis.
    J Cancer Res Clin Oncol. 2023 Jul 21. doi: 10.1007/s00432-023-05192.
    PubMed    
    Abstract available

  284. BROMLEY-DULFANO RA, Rossin-Slater M, Bundorf MK
    Association Between Cervical Cancer Screening Guidelines and Preterm Delivery Among Females Aged 18 to 24 Years.
    JAMA Health Forum. 2023;4:e231974.
    PubMed    
    Abstract available

  285. ZANG L, Chen Q, Lin A, Chen J, et al
    A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy.
    World J Surg Oncol. 2023;21:210.
    PubMed    
    Abstract available

  286. CHEN F, Di W, Hu YJ, Li CZ, et al
    [Evaluation of the efficacy and safety of Nocardia rubra cell wall skeleton immunotherapy for cervical high-risk HPV persistent infection].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:536-545.
    PubMed    
    Abstract available

  287. WU MX, He XM, You ZX
    [Analysis of natural regression and influencing factors of HSIL in the cervix of childbearing age patients].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:516-525.
    PubMed    
    Abstract available

  288. MISTRY S, Thakkar M, Singh AK, Patel D, et al
    Synthesis, in vitro cytotoxic activity and molecular docking study of androstene and estrone derivatives.
    Steroids. 2023;197:109259.
    PubMed    
    Abstract available

  289. YAPINDI L, Bowley T, Kurtaneck N, Bergeson RL, et al
    Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.
    Virology. 2023;585:1-20.
    PubMed    
    Abstract available

  290. KHAMISY-FARAH R, Endrawis M, Odeh M, Tuma R, et al
    Knowledge of Human Papillomavirus (HPV), Attitudes, and Practices Towards Anti-HPV Vaccination Among Israeli Nurses.
    J Cancer Educ. 2023;38:1391-1396.
    PubMed    
    Abstract available

  291. LA FRINERE-SANDOVAL QNNB, Cubbin C, DiNitto DM
    Racial and ethnic disparities in cervical and breast cancer screenings by nativity and length of U.S. residence.
    Ethn Health. 2023;28:895-911.
    PubMed    
    Abstract available

  292. LYU Y, Song L, Mao R, Liu C, et al
    hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization.
    J Cancer Res Clin Oncol. 2023;149:6225-6237.
    PubMed    
    Abstract available

  293. KERRISON RS, Jones A, Peng J, Price G, et al
    Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
    Br J Cancer. 2023;129:81-93.
    PubMed    
    Abstract available

  294. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    PubMed    
    Abstract available

  295. XU H, Chen Y, Zhao C, Wang Q, et al
    Bethesda system reporting rates, histological follow-up and HPV genotypes distribution of abnormal cytology in Anhui province of China: Analysis of 93,168 cervical liquid-based cytology test reports.
    Diagn Cytopathol. 2023;51:501-510.
    PubMed    
    Abstract available

  296. AGOFF SN, Brockmeyer AD, Barrie AM, Larson J, et al
    High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Diagn Cytopathol. 2023;51:475-479.
    PubMed    
    Abstract available

  297. DONG H, Li H, Wang L, Yuan Y, et al
    Clinical analysis of 175 cases of vaginal intraepithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2023;287:232-236.
    PubMed    
    Abstract available

  298. LI J, Xue X, Zhang Y, Ding F, et al
    The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Gynecol Oncol. 2023;175:133-141.
    PubMed    
    Abstract available

  299. SCHIFFMAN M, Mirabello L, Egemen D, Befano B, et al
    The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
    Gynecol Oncol. 2023;174:253-261.
    PubMed    
    Abstract available

  300. STOLER MH, Parvu V, Yanson K, Andrews J, et al
    Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2023;174:68-75.
    PubMed    
    Abstract available

  301. KAHVECIOGLU A, Gurlek E, Yedekci FY, Sari SY, et al
    Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy.
    Gynecol Oncol. 2023;176:10-15.
    PubMed    
    Abstract available

  302. EIDE AJ, Halle MK, Lura N, Fasmer KE, et al
    Visceral fat percentage for prediction of outcome in uterine cervical cancer.
    Gynecol Oncol. 2023;176:62-68.
    PubMed    
    Abstract available

  303. KONSKI A, Deshmukh S, Klopp AH, Yeung AR, et al
    Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
    Gynecol Oncol. 2023;175:176-181.
    PubMed    
    Abstract available

  304. MAH SJ, Carter Ramirez DM, Eiriksson LR, Schnarr K, et al
    Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018.
    Gynecol Oncol. 2023;175:169-175.
    PubMed    
    Abstract available

  305. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.
    PubMed    


  306. BOGANI G, Ghelardi A, Sopracordevole F, Annoni M, et al
    Human papillomavirus (HPV) vaccination: a call for action in Italy.
    Int J Gynecol Cancer. 2023;33:1132-1139.
    PubMed    
    Abstract available

  307. MORTON M, Marcu I, Levine M, Cosgrove C, et al
    Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005243.
    PubMed    
    Abstract available

  308. PENG H, Zhang J, Xu N, Zhou Y, et al
    Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
    BMC Cancer. 2023;23:588.
    PubMed    
    Abstract available

  309. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
    Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
    BMC Cancer. 2023;23:631.
    PubMed    
    Abstract available

  310. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
    Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    BMC Cancer. 2023;23:653.
    PubMed    
    Abstract available

  311. ZHANG C, Gu L, Xiao J, Jin F, et al
    Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    BMC Cancer. 2023;23:684.
    PubMed    
    Abstract available

  312. MUSA J, Maiga M, Green SJ, Magaji FA, et al
    Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    BMC Cancer. 2023;23:683.
    PubMed    
    Abstract available

  313. TRANBERG M, Petersen LK, Hammer A, Elfstrom M, et al
    Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.
    PLoS Med. 2023;20:e1004253.
    PubMed    
    Abstract available

  314. JONSDOTTIR B, Wikman A, Sundstrom Poromaa I, Stalberg K, et al
    Advanced gynecological cancer: Quality of life one year after diagnosis.
    PLoS One. 2023;18:e0287562.
    PubMed    
    Abstract available

  315. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    PubMed    
    Abstract available

  316. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    PubMed    
    Abstract available

  317. MAHAJAN H, Reddy N, Devi NGM, Poli UR, et al
    Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
    PLoS One. 2023;18:e0278357.
    PubMed    
    Abstract available

  318. FAZLOLLAHPOUR-NAGHIBI A, Bagheri K, Almukhtar M, Taha SR, et al
    Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288443.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;